NOVARTIS INDIA
|
NOVARTIS INDIA Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 40.88 | 34.52 | 41.88 | -1.51 | 8.47 |
| CEPS(Rs) | 41.77 | 35.58 | 44.34 | 2.40 | 13.40 |
| DPS(Rs) | 25.00 | 25.00 | 47.50 | 10.00 | 10.00 |
| Book NAV/Share(Rs) | 318.06 | 301.79 | 314.30 | 281.17 | 289.36 |
| Tax Rate(%) | 22.63 | 30.65 | 10.42 | 2.62 | 47.80 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 23.44 | 17.79 | 15.74 | 5.50 | 5.66 |
| EBIT Margin(%) | 33.63 | 33.89 | 28.33 | 0.21 | 10.52 |
| Pre Tax Margin(%) | 33.43 | 33.49 | 27.90 | -0.78 | 8.82 |
| PAT Margin (%) | 25.87 | 23.22 | 25.00 | -0.76 | 4.61 |
| Cash Profit Margin (%) | 26.43 | 23.93 | 26.46 | 1.22 | 7.29 |
| Performance Ratios | |||||
| ROA(%) | 5.35 | 4.35 | 5.09 | -0.18 | 1.22 |
| ROE(%) | 13.19 | 11.21 | 14.07 | -0.53 | 2.91 |
| ROCE(%) | 17.15 | 16.35 | 15.96 | 0.14 | 6.67 |
| Asset Turnover(x) | 0.21 | 0.19 | 0.20 | 0.23 | 0.26 |
| Sales/Fixed Asset(x) | 20.84 | 10.90 | 10.39 | 8.43 | 5.68 |
| Working Capital/Sales(x) | 0.65 | 0.68 | 0.80 | 0.99 | 0.80 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.05 | 0.09 | 0.10 | 0.12 | 0.18 |
| Receivable days | 38.18 | 38.62 | 35.62 | 31.23 | 30.70 |
| Inventory Days | 40.22 | 49.54 | 49.34 | 39.38 | 42.89 |
| Payable days | 101.73 | 110.74 | 119.32 | 130.52 | 159.09 |
| Valuation Parameters | |||||
| PER(x) | 19.20 | 29.80 | 13.50 | - | 65.18 |
| PCE(x) | 18.79 | 28.91 | 12.75 | 245.74 | 41.21 |
| Price/Book(x) | 2.47 | 3.41 | 1.80 | 2.10 | 1.91 |
| Yield(%) | 3.18 | 2.43 | 8.40 | 1.69 | 1.81 |
| EV/Net Sales(x) | 3.62 | 5.80 | 2.22 | 2.35 | 2.26 |
| EV/Core EBITDA(x) | 9.67 | 15.30 | 6.81 | 15.58 | 14.42 |
| EV/EBIT(x) | 9.83 | 15.62 | 7.16 | 930.30 | 18.09 |
| EV/CE(x) | 1.64 | 2.61 | 1.08 | 0.47 | 0.39 |
| M Cap / Sales | 5.44 | 7.58 | 3.68 | 3.64 | 3.57 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 6.33 | -11.53 | -5.28 | 4.86 | -12.98 |
| Core EBITDA Growth(%) | 5.07 | 3.04 | 104.30 | 0.70 | 24.31 |
| EBIT Growth(%) | 5.52 | 6.15 | - | -97.88 | 36.23 |
| PAT Growth(%) | 18.44 | -17.58 | 2,878.49 | -117.80 | 107.34 |
| EPS Growth(%) | 18.44 | -17.58 | 2,878.48 | -117.80 | 107.34 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 2.42 | 2.36 | 2.93 | 2.47 | 2.58 |
| Quick Ratio(x) | 2.32 | 2.24 | 2.73 | 2.30 | 2.45 |
| Interest Cover(x) | 170.38 | 83.44 | 66.93 | 0.21 | 6.21 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of NOVARTIS INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOVARTIS INDIA | ₹2,029.8 Cr | 0.1% | -6.3% | -18.8% | Stock Analytics | |
| ADANI ENTERPRISES | ₹310,082.0 Cr | -1.6% | -2.9% | -11.4% | Stock Analytics | |
| REDINGTON | ₹22,757.4 Cr | 0.2% | 9.7% | 47% | Stock Analytics | |
| HONASA CONSUMER | ₹9,445.5 Cr | 0.7% | 5.8% | 8.7% | Stock Analytics | |
| MMTC | ₹9,036.0 Cr | -6.8% | -10.7% | -16.7% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,818.9 Cr | -8.8% | -16.2% | 42.9% | Stock Analytics | |
NOVARTIS INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOVARTIS INDIA | 0.1% |
-6.3% |
-18.8% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses